5-amino-1mq bioavailability oral vs subcutaneous Research Guide: NNMT Inhibitor Mechanism Peptide Therapy - 5-Amino-1MQ –
Description
The most commonly reported events in active arms were mild and transient: injection site reactions in some subcutaneous subjects, occasional headache, and in some oral dosing arms, minor gastrointestinal tolerance issues
AOD-9604 is not a substitute for GLP-1 agonists in clinical obesity
It does not work through appetite suppression, so eating behavior remains normal
Cycling theoretically prevents tolerance and allows natural enzyme function to reset
